Free Trial
→ The 1934 playbook (From American Alternative) (Ad)tc pixel Free NAKA Stock Alerts

KindlyMD (NAKA) Competitors

KindlyMD logo
$0.20 +0.00 (+2.09%)
As of 04:00 PM Eastern
Compare

NAKA vs. FLGT, AGL, VMD, AUNA, and TOI

Should you be buying KindlyMD stock or one of its competitors? The main competitors of KindlyMD include Fulgent Genetics (FLGT), Agilon Health (AGL), Viemed Healthcare (VMD), Auna (AUNA), and Oncology Institute (TOI). These companies are all part of the "healthcare" industry.

How does KindlyMD compare to Fulgent Genetics?

Fulgent Genetics (NASDAQ:FLGT) and KindlyMD (NASDAQ:NAKA) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, valuation, earnings, media sentiment, analyst recommendations, profitability, risk and dividends.

Fulgent Genetics currently has a consensus target price of $27.00, indicating a potential upside of 81.21%. KindlyMD has a consensus target price of $0.75, indicating a potential upside of 284.62%. Given KindlyMD's stronger consensus rating and higher possible upside, analysts plainly believe KindlyMD is more favorable than Fulgent Genetics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Fulgent Genetics
1 Sell rating(s)
2 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.20
KindlyMD
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40

48.1% of Fulgent Genetics shares are owned by institutional investors. 36.2% of Fulgent Genetics shares are owned by insiders. Comparatively, 24.5% of KindlyMD shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Fulgent Genetics has a beta of 0.88, meaning that its stock price is 12% less volatile than the S&P 500. Comparatively, KindlyMD has a beta of 17.12, meaning that its stock price is 1,612% more volatile than the S&P 500.

KindlyMD has lower revenue, but higher earnings than Fulgent Genetics. Fulgent Genetics is trading at a lower price-to-earnings ratio than KindlyMD, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Fulgent Genetics$322.67M1.37-$60.51M-$2.39N/A
KindlyMD$1.82M73.93-$52.23M-$0.87N/A

Fulgent Genetics has a net margin of -23.04% compared to KindlyMD's net margin of -2,866.57%. Fulgent Genetics' return on equity of -3.24% beat KindlyMD's return on equity.

Company Net Margins Return on Equity Return on Assets
Fulgent Genetics-23.04% -3.24% -2.97%
KindlyMD -2,866.57%-16.11%-11.25%

In the previous week, Fulgent Genetics had 6 more articles in the media than KindlyMD. MarketBeat recorded 7 mentions for Fulgent Genetics and 1 mentions for KindlyMD. KindlyMD's average media sentiment score of 1.02 beat Fulgent Genetics' score of -0.37 indicating that KindlyMD is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Fulgent Genetics
0 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
KindlyMD
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

KindlyMD beats Fulgent Genetics on 9 of the 16 factors compared between the two stocks.

How does KindlyMD compare to Agilon Health?

Agilon Health (NYSE:AGL) and KindlyMD (NASDAQ:NAKA) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their dividends, institutional ownership, media sentiment, earnings, analyst recommendations, risk, profitability and valuation.

Agilon Health has a net margin of -6.60% compared to KindlyMD's net margin of -2,866.57%. KindlyMD's return on equity of -16.11% beat Agilon Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Agilon Health-6.60% -120.82% -24.89%
KindlyMD -2,866.57%-16.11%-11.25%

In the previous week, Agilon Health had 7 more articles in the media than KindlyMD. MarketBeat recorded 8 mentions for Agilon Health and 1 mentions for KindlyMD. KindlyMD's average media sentiment score of 1.02 beat Agilon Health's score of -0.18 indicating that KindlyMD is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Agilon Health
1 Very Positive mention(s)
0 Positive mention(s)
4 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Neutral
KindlyMD
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Agilon Health has a beta of 2.29, suggesting that its share price is 129% more volatile than the S&P 500. Comparatively, KindlyMD has a beta of 17.12, suggesting that its share price is 1,612% more volatile than the S&P 500.

Agilon Health currently has a consensus target price of $38.48, indicating a potential upside of 44.50%. KindlyMD has a consensus target price of $0.75, indicating a potential upside of 284.62%. Given KindlyMD's stronger consensus rating and higher possible upside, analysts plainly believe KindlyMD is more favorable than Agilon Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Agilon Health
3 Sell rating(s)
9 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.00
KindlyMD
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40

KindlyMD has lower revenue, but higher earnings than Agilon Health. Agilon Health is trading at a lower price-to-earnings ratio than KindlyMD, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Agilon Health$5.93B0.07-$391.35M-$23.75N/A
KindlyMD$1.82M73.93-$52.23M-$0.87N/A

Summary

KindlyMD beats Agilon Health on 10 of the 13 factors compared between the two stocks.

How does KindlyMD compare to Viemed Healthcare?

Viemed Healthcare (NASDAQ:VMD) and KindlyMD (NASDAQ:NAKA) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their dividends, institutional ownership, media sentiment, earnings, analyst recommendations, risk, profitability and valuation.

Viemed Healthcare has a net margin of 5.53% compared to KindlyMD's net margin of -2,866.57%. Viemed Healthcare's return on equity of 10.72% beat KindlyMD's return on equity.

Company Net Margins Return on Equity Return on Assets
Viemed Healthcare5.53% 10.72% 7.82%
KindlyMD -2,866.57%-16.11%-11.25%

In the previous week, Viemed Healthcare had 1 more articles in the media than KindlyMD. MarketBeat recorded 2 mentions for Viemed Healthcare and 1 mentions for KindlyMD. KindlyMD's average media sentiment score of 1.02 beat Viemed Healthcare's score of 0.00 indicating that KindlyMD is being referred to more favorably in the news media.

Company Overall Sentiment
Viemed Healthcare Neutral
KindlyMD Positive

Viemed Healthcare has a beta of 1.15, meaning that its share price is 15% more volatile than the S&P 500. Comparatively, KindlyMD has a beta of 17.12, meaning that its share price is 1,612% more volatile than the S&P 500.

KindlyMD has a consensus target price of $0.75, indicating a potential upside of 284.62%. Given KindlyMD's stronger consensus rating and higher possible upside, analysts plainly believe KindlyMD is more favorable than Viemed Healthcare.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Viemed Healthcare
0 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
KindlyMD
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40

74.2% of Viemed Healthcare shares are owned by institutional investors. 20.0% of Viemed Healthcare shares are owned by insiders. Comparatively, 24.5% of KindlyMD shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Viemed Healthcare has higher revenue and earnings than KindlyMD. KindlyMD is trading at a lower price-to-earnings ratio than Viemed Healthcare, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Viemed Healthcare$270.28M1.38$14.93M$0.3726.22
KindlyMD$1.82M73.93-$52.23M-$0.87N/A

Summary

Viemed Healthcare beats KindlyMD on 9 of the 16 factors compared between the two stocks.

How does KindlyMD compare to Auna?

KindlyMD (NASDAQ:NAKA) and Auna (NYSE:AUNA) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, valuation, analyst recommendations, risk, media sentiment, earnings, dividends and institutional ownership.

KindlyMD presently has a consensus target price of $0.75, suggesting a potential upside of 284.62%. Auna has a consensus target price of $7.30, suggesting a potential upside of 45.07%. Given KindlyMD's higher probable upside, equities analysts plainly believe KindlyMD is more favorable than Auna.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
KindlyMD
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40
Auna
1 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
2.40

Auna has higher revenue and earnings than KindlyMD. KindlyMD is trading at a lower price-to-earnings ratio than Auna, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
KindlyMD$1.82M73.93-$52.23M-$0.87N/A
Auna$4.39B0.08$27.39M$0.3613.98

KindlyMD has a beta of 17.12, meaning that its stock price is 1,612% more volatile than the S&P 500. Comparatively, Auna has a beta of 1.03, meaning that its stock price is 3% more volatile than the S&P 500.

Auna has a net margin of 2.13% compared to KindlyMD's net margin of -2,866.57%. Auna's return on equity of 19.23% beat KindlyMD's return on equity.

Company Net Margins Return on Equity Return on Assets
KindlyMD-2,866.57% -16.11% -11.25%
Auna 2.13%19.23%4.70%

In the previous week, KindlyMD had 1 more articles in the media than Auna. MarketBeat recorded 1 mentions for KindlyMD and 0 mentions for Auna. KindlyMD's average media sentiment score of 1.02 beat Auna's score of 1.00 indicating that KindlyMD is being referred to more favorably in the media.

Company Overall Sentiment
KindlyMD Positive
Auna Positive

Summary

Auna beats KindlyMD on 8 of the 14 factors compared between the two stocks.

How does KindlyMD compare to Oncology Institute?

KindlyMD (NASDAQ:NAKA) and Oncology Institute (NASDAQ:TOI) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, valuation, analyst recommendations, risk, media sentiment, earnings, dividends and institutional ownership.

KindlyMD presently has a consensus target price of $0.75, suggesting a potential upside of 284.62%. Oncology Institute has a consensus target price of $7.00, suggesting a potential upside of 75.88%. Given KindlyMD's higher probable upside, equities analysts plainly believe KindlyMD is more favorable than Oncology Institute.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
KindlyMD
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40
Oncology Institute
1 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.60

KindlyMD has higher earnings, but lower revenue than Oncology Institute. Oncology Institute is trading at a lower price-to-earnings ratio than KindlyMD, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
KindlyMD$1.82M73.93-$52.23M-$0.87N/A
Oncology Institute$502.73M0.78-$60.61M-$0.56N/A

KindlyMD has a beta of 17.12, suggesting that its share price is 1,612% more volatile than the S&P 500. Comparatively, Oncology Institute has a beta of 0.33, suggesting that its share price is 67% less volatile than the S&P 500.

36.9% of Oncology Institute shares are held by institutional investors. 24.5% of KindlyMD shares are held by company insiders. Comparatively, 8.5% of Oncology Institute shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Oncology Institute has a net margin of -11.45% compared to KindlyMD's net margin of -2,866.57%. Oncology Institute's return on equity of 0.00% beat KindlyMD's return on equity.

Company Net Margins Return on Equity Return on Assets
KindlyMD-2,866.57% -16.11% -11.25%
Oncology Institute -11.45%N/A -33.70%

In the previous week, Oncology Institute had 1 more articles in the media than KindlyMD. MarketBeat recorded 2 mentions for Oncology Institute and 1 mentions for KindlyMD. KindlyMD's average media sentiment score of 1.02 beat Oncology Institute's score of 0.00 indicating that KindlyMD is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
KindlyMD
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Oncology Institute
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

KindlyMD and Oncology Institute tied by winning 8 of the 16 factors compared between the two stocks.

Get KindlyMD News Delivered to You Automatically

Sign up to receive the latest news and ratings for NAKA and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NAKA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NAKA vs. The Competition

Export
MetricKindlyMDMedical Services IndustryMedical SectorNASDAQ Exchange
Market Cap$134.55M$8.11B$6.25B$11.87B
Dividend YieldN/A2.18%2.73%5.21%
P/E Ratio-0.2224.8429.0428.47
Price / Sales73.9317.51476.6160.94
Price / CashN/A13.2327.6236.52
Price / Book0.174.949.676.67
Net Income-$52.23M$183.43M$3.55B$332.53M
7 Day Performance4.78%0.19%1.70%2.01%
1 Month Performance-10.55%5.27%5.62%9.20%
1 Year PerformanceN/A0.38%34.42%39.59%

KindlyMD Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NAKA
KindlyMD
4.1298 of 5 stars		$0.20
+2.1%		$0.75
+284.6%		N/A$134.55M$1.82MN/AN/A
FLGT
Fulgent Genetics
2.3444 of 5 stars		$14.81
-3.2%		$32.00
+116.1%		N/A$440.45M$322.67MN/A1,315
AGL
Agilon Health
2.8516 of 5 stars		$25.96
-7.0%		$40.23
+55.0%		N/A$432.48M$5.93BN/A1,076
VMD
Viemed Healthcare
2.3754 of 5 stars		$9.89
-1.6%		N/AN/A$380.38M$270.28M26.721,382
AUNA
Auna
4.7852 of 5 stars		$5.12
-3.2%		$7.30
+42.6%		N/A$378.95M$4.39B14.2214,842

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:NAKA) was last updated on 5/5/2026 by MarketBeat.com Staff.
From Our Partners
Iran's New Leader Just Said Something That Should Terrify Every American
Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...
American Alternative | Sponsoredtc pixel
Your book attached
Your Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...
Profits Run | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
The $1.75T "Backdoor" ticker (NOT Starlink)
When the SpaceX IPO launches, most investors will already be too late. The real opportunity isn't the IPO itse...
Behind the Markets | Sponsoredtc pixel
Sell 99% of Your Stocks, Do THIS Instead…
Millionaire Trader Exposes: "The Single Stock Income Plan" With over 6,000 stocks on the market to choose ...
The Oxford Club | Sponsoredtc pixel
Trade this between 9:30 and 10:45 am EST
The first 75 minutes of the trading day may be the most overlooked window for consistent opportunities.If you ...
Base Camp Trading | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
Elon Unveils AI Passive Income Stream for Millions of Americans
During Tesla's last earnings call, Elon Musk outlined a new AI-driven approach he says could generate $30,000-...
InvestorPlace | Sponsoredtc pixel